A03. Horizon Scanning and HTA: Past, Present and Future
Tracks
Reimbursement/Market Access
| Tuesday, June 3, 2025 |
| 11:15 AM - 12:15 PM |
| Parkside 1 |
Chair & Speakers
Dr Orin Chisholm
Program Director, PMDD Programs
University Of Sydney
Horizon Scanning and HTA: Past, Present and Future
Abstract
Panel discussion on future opportunities for horizon scanning to support HTA, evolution under HTA Reform process, reflecting on 17-year history and future implementation challenges.
Provide foundational information about Horizon Scanning and HTA's past and present, which would likely help attendees better understand the next session on HTA Reform.
Provide foundational information about Horizon Scanning and HTA's past and present, which would likely help attendees better understand the next session on HTA Reform.
Biography
Orin is the program director for the postgraduate programs in Pharmaceutical and Medical Device Development at the University of Sydney. She has academic appointments with UNSW and Arizona State University, USA. Orin has previously spent many years in industry roles and is a consultant in regulatory affairs. She is on the Board of the Association of Graduate Regulatory Educators (USA) and on the editorial advisory committee for the Regulatory Affairs Professionals Society (RAPS) in the USA. Orin received the Organisation for Professionals in Regulatory Affairs (TOPRA), UK award for excellence in regulatory education in 2017; became a Senior Fellow of the Higher Education Academy (UK) in 2018 and was elected a Fellow of RAPS in 2021. Her research focuses on regulatory science, workforce development and pharmaceutical policy.
Mr George Papadopoulos
Director & Partner
LUCID HEALTH CONSULTING
Horizon Scanning and HTA: Past, Present and Future
Abstract
As the final session in the Market Access stream, this interactive panel invites peers to reflect, recharge, and look ahead. Chaired by long-time industry leader George Papadopoulos, the session brings together a diverse panel — Matt Britland (established industry expert), Sara Norris (government and policy), and Ella Day (early-career perspective) — for a candid discussion on how our profession is evolving.
Together, they will discuss:
• The future skillsets needed across industry, policy, and consultancy
• Building professional resilience, relevance, and influence
• Lessons learned across decades, and what emerging professionals can teach us
With practical takeaways and space for audience discussion, this energising session will leave you with new perspectives and an action plan to support your next chapter. Whether you are just starting out or helping shape the future of pharmaceuticals or medtech, this is a session not to miss.
Together, they will discuss:
• The future skillsets needed across industry, policy, and consultancy
• Building professional resilience, relevance, and influence
• Lessons learned across decades, and what emerging professionals can teach us
With practical takeaways and space for audience discussion, this energising session will leave you with new perspectives and an action plan to support your next chapter. Whether you are just starting out or helping shape the future of pharmaceuticals or medtech, this is a session not to miss.
Biography
Dr Franz Pichler
Founder And Principal
Confluence Health Consulting
Horizon Scanning and HTA: Past, Present and Future
Abstract
Panel discussion on future opportunities for horizon scanning to support HTA, evolution under HTA Reform process, reflecting on 17-year history and future implementation challenges.
Provide foundational information about Horizon Scanning and HTA's past and present, which would likely help attendees better understand the next session on HTA Reform.
Provide foundational information about Horizon Scanning and HTA's past and present, which would likely help attendees better understand the next session on HTA Reform.
Biography
